Alzheimer's research

Sarasota's Roskamp Institute was the first to discover a protein that tends to form clumps in the brains of people with Alzheimer's. A new drug has been shown to reduce it.

In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.

Microglia are amoeba-like cells that scour the brain for injuries and invaders. But sometimes the usually helpful cells go into overdrive and damage the brain, researchers say.

Aduhelm is the first treatment approved in the country to slow cognitive decline in those living with Alzheimer's. Doctors have refused to prescribe it, given the lack of data and evidence behind it.

Lowering blood pressure more than usually recommended not only helps prevent heart problems, it also cuts the risk of mental decline that often leads to…

With a large aging population, Florida is an epicenter of Alzheimer’s cases in the United States. Roughly half a million people in the state live with...

Julie Martin sits at a table in a nondescript room at Suncoast Hospice in Clearwater. She strums an instrument called a Qchord, a type of electronic…

Music is often part of some of our biggest moments. From singing happy birthday to your favorite song that you always sing along to, music can help you...